Active substance:
- Escherichia coli, serotype O149:K88 (fimbrial adhesin F4), Inactivated
- Escherichia coli, strain O8:K87, K88, fimbrial adhesin F4, Inactivated
- Escherichia coli, serotype O101:K99 (fimbrial adhesin F5), Inactivated
- Escherichia coli, serotype O9 (fimbrial adehsin F6), Inactivated
- Clostridium perfringens, type B, C and D, beta toxoid
Route of administration:
-
Subcutaneous use
-
Intramuscular use
Pharmaceutical form:
-
Suspension for injection
Target species:
-
Pig (piglet)